- Home
- JZXN vs RVPH Comparison
JZXN vs RVPH Comparison
Compare JZXN & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JZXN
- RVPH
- Stock Information
- Founded
- JZXN 2019
- RVPH 2006
- Country
- JZXN China
- RVPH United States
- Employees
- JZXN N/A
- RVPH N/A
- Industry
- JZXN Retail-Auto Dealers and Gas Stations
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- JZXN Consumer Discretionary
- RVPH Health Care
- Exchange
- JZXN Nasdaq
- RVPH Nasdaq
- Market Cap
- JZXN 16.2M
- RVPH 18.1M
- IPO Year
- JZXN 2021
- RVPH N/A
- Fundamental
- Price
- JZXN $0.18
- RVPH $0.51
- Analyst Decision
- JZXN
- RVPH Strong Buy
- Analyst Count
- JZXN 0
- RVPH 6
- Target Price
- JZXN N/A
- RVPH $3.33
- AVG Volume (30 Days)
- JZXN 6.2M
- RVPH 4.0M
- Earning Date
- JZXN 03-05-2026
- RVPH 11-13-2025
- Dividend Yield
- JZXN N/A
- RVPH N/A
- EPS Growth
- JZXN N/A
- RVPH N/A
- EPS
- JZXN N/A
- RVPH N/A
- Revenue
- JZXN $97,465.00
- RVPH N/A
- Revenue This Year
- JZXN N/A
- RVPH N/A
- Revenue Next Year
- JZXN N/A
- RVPH N/A
- P/E Ratio
- JZXN N/A
- RVPH N/A
- Revenue Growth
- JZXN N/A
- RVPH N/A
- 52 Week Low
- JZXN $0.17
- RVPH $0.25
- 52 Week High
- JZXN $7.82
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- JZXN 30.49
- RVPH 47.40
- Support Level
- JZXN $0.17
- RVPH $0.48
- Resistance Level
- JZXN $0.22
- RVPH $0.54
- Average True Range (ATR)
- JZXN 0.03
- RVPH 0.05
- MACD
- JZXN 0.01
- RVPH -0.00
- Stochastic Oscillator
- JZXN 7.87
- RVPH 41.32
About JZXN Jiuzi Holdings Inc.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its operating segments are propretaey product; and resale of sourced Equipment and accessories from third party products. The company generates a majority of its revenue from the propretaey product segment. Geographically, the firm operates in China.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.